Clinical Trials Sponsored by Ananda Hemp, Inc.

Total 322 results

Main Line Health
Ananda Hemp, Inc.

Active, not recruiting

Effect of Hemp-CBD on Patients With CIPN (Coala-T-CBD)

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Chemotherapy-induced Peripheral Neuropathy | Uterine Cancer

United States
Eastern Virginia Medical School
Old Dominion University; Ananda Hemp, Inc.

Recruiting

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Dementia | Alzheimer Disease | Major Neurocognitive Disorder With Aggressive Behavior

United States
Prima-Temp, Inc

Unknown

Measuring Core Body Temperature Using TempuRing

Fertility

United States
Hemo Sapiens, Inc.

Completed

BEtter Control of Blood Pressure in Hypertensive pAtients Monitored Using the HOTMAN® sYstem (BEAUTY)

Hypertension

France, Estonia, Italy, Norway, Poland
HEM Pharma Inc.
Premier Research Group plc

Not yet recruiting

HEM1036 Phase 2 Study in Low Anterior Resection Syndrome

LARS - Low Anterior Resection Syndrome
Endominance
Dr. John J. Ratey; HEM Pharma Inc.

Recruiting

Microbiome, Anxiety and Cognitive Orientation Study (MACO)

Depression | Mood Disorders | Anxiety | Microbiome | Neurodegeneration

United States
Otsuka Canada Pharmaceutical Inc.
Lundbeck Canada Inc.

Recruiting

Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) (INITIATE)

Schizophrenia | Schizo Affective Disorder | Bipolar I Disorder

Canada
Associated Scientists to Help Minimize Allergies
Eisai Inc.; Janssen Pharmaceuticals

Completed

Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.

Asthma | Gastroesophageal Reflux Disease

United States
Enanta Pharmaceuticals, Inc

Completed

Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects

COVID-19

United States
Enanta Pharmaceuticals, Inc

Completed

Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects

Respiratory Syncytial Virus (RSV)

United States
Enanta Pharmaceuticals, Inc

Terminated

A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.

Chronic Hepatitis B Virus Infection

New Zealand
ATGen Canada Inc

Terminated

Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy (ANKA-HR)

Colorectal Cancer | Immunity, Innate

Canada
ATGen Canada Inc

Terminated

Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy (ANKA-PCA)

Prostatic Neoplasm | Immunity, Innate

Canada
Lundbeck Canada Inc.

Completed

Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine (AtWoRC)

Major Depressive Disorder

Canada
Enanta Pharmaceuticals, Inc

Completed

Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.

NASH

United States
Biotronik Canada Inc

Completed

Clinical Investigation Plan for the AVOPT Data Collection Clinical Study

Cardiac Pacemaker, Artificial

Canada
Enanta Pharmaceuticals, Inc

Completed

Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788

Safety in Normal Volunteers

United States
Enanta Pharmaceuticals, Inc

Completed

Two-way Interaction Between Alisporivir and EDP239

Hepatitis C Virus

Germany
Enanta Pharmaceuticals, Inc

Recruiting

A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 (SPRINT)

COVID-19

United States
Enanta Pharmaceuticals, Inc

Recruiting

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. (RSVHR)

RSV Infection

United States, Poland, Spain, Taiwan, Bulgaria, Argentina, Puerto Rico, Czechia, Brazil, Israel, Malaysia, Netherlands, Slovakia, South Africa
Enanta Pharmaceuticals, Inc

Terminated

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Who Are Infected With Acute Respiratory Syncytial Virus (RSV) of the Upper Respiratory Tract (RSVTx)

Respiratory Syncytial Virus Infections

Spain, Korea, Republic of, Israel, Canada, United States, Italy, France, Belgium, Brazil, Taiwan, Greece, Argentina, Mexico, South Africa, China, Poland, Colombia, Turkey, United Kingdom
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-323 in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc

Terminated

A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

Non-Alcoholic Steatohepatitis

United States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
Enanta Pharmaceuticals, Inc

Completed

Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.

COVID-19

United States
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-235 in Healthy Subjects

SARS CoV 2 Infection

United States
Enanta Pharmaceuticals, Inc

Completed

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

NASH - Nonalcoholic Steatohepatitis

United States
Enanta Pharmaceuticals, Inc

Completed

Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects

NASH - Nonalcoholic Steatohepatitis

United States
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

NASH

United States, Czechia, Slovakia
Biotronik Canada Inc

Completed

BIOFLOW-III Canada Satellite Registry

Myocardial Ischemia | Coronary Artery Disease

Canada
Lundbeck Canada Inc.

Completed

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia (BENDACT)

Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin's Lymphoma

Canada
Enanta Pharmaceuticals, Inc

Completed

Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects

Hepatitis C

United States, Germany
Enanta Pharmaceuticals, Inc

Terminated

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788

Healthy

United States
BioSyntech Canada Inc.

Terminated

BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer

Canada
Oncothyreon Canada Inc.

Completed

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

Breast Neoplasms

United States
Evolus, Inc.
Avania

Recruiting

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Glabellar Frown Lines

Germany
Enanta Pharmaceuticals, Inc

Recruiting

A Study to Evaluate EDP 938 Regimens in Children With RSV (RSVPEDs)

Respiratory Syncytial Virus (RSV)

United States, Spain, Israel, Australia, Germany, Korea, Republic of, Taiwan, United Kingdom, Argentina, Brazil, New Zealand, Poland, Romania, South Africa, Mexico
Enanta Pharmaceuticals, Inc

Completed

Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc

Completed

Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers

NASH - Nonalcoholic Steatohepatitis

United States
Enanta Pharmaceuticals, Inc

Completed

Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers

MRSA, SSTI

United States
Enanta Pharmaceuticals, Inc

Completed

Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers

Methicillin-resistant Staphylococcus Aureus | Skin and Soft Tissue Infections

United States
Enanta Pharmaceuticals, Inc

Unknown

Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia

Community Acquired Pneumonia

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Canada Pharmaceutical Inc.; Lundbeck Canada Inc.

Completed

Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Major Depressive Disorder

Canada
Gefion Canada Inc.
KGK Science Inc.

Completed

A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults

CBD | Biological Availability | Skin Absorption | THC

Canada
Janssen-Ortho Inc., Canada
Ortho Biotech Canada

No longer available

A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients

Multiple Myeloma

Canada
SBI ALApharma Canada, Inc.

Recruiting

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

Breast Cancer | Breast Neoplasm Female

United States
ActiveProtective Technologies, Inc
Avania

Completed

Mitigation of Major Hip Injury Due to Fall With a Smart Belt

Hip Injuries | Osteoporosis | Osteoporosis Risk | Fall Injury | Fractures, Hip | Fall Risk

United States
Aquinox Pharmaceuticals (Canada) Inc.

Completed

Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study (DDI-COC)

Healthy Volunteer

Netherlands
Aquinox Pharmaceuticals (Canada) Inc.

Completed

Efficacy and Safety of AQX-1125 in Unstable COPD (FLAGSHIP)

COPD

United States, New Zealand, Poland, Australia, Denmark, Finland, Hungary, Sweden
Janssen-Ortho Inc., Canada

Terminated

A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication

Schizophrenia

Canada, United Kingdom, Australia, Ireland
Janssen-Ortho Inc., Canada

Completed

Impact of Tolerability Issues on Chronic Pain

Pain

Clinical Trials Sponsored by Ananda Hemp, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations